362 related articles for article (PubMed ID: 26908152)
1. Factors influencing topiramate clearance in adult patients with epilepsy: A population pharmacokinetic analysis.
Bae EK; Lee J; Shin JW; Moon J; Lee KJ; Shin YW; Kim TJ; Shin D; Jang IJ; Lee SK
Seizure; 2016 Apr; 37():8-12. PubMed ID: 26908152
[TBL] [Abstract][Full Text] [Related]
2. Population pharmacokinetics of topiramate in adult patients with epilepsy using nonlinear mixed effects modelling.
Jovanović M; Sokić D; Grabnar I; Vovk T; Prostran M; Vučićević K; Miljković B
Eur J Pharm Sci; 2013 Nov; 50(3-4):282-9. PubMed ID: 23891703
[TBL] [Abstract][Full Text] [Related]
3. Cross-reactivity of skin rashes with current antiepileptic drugs in Chinese population.
Wang XQ; Lang SY; Shi XB; Tian HJ; Wang RF; Yang F
Seizure; 2010 Nov; 19(9):562-6. PubMed ID: 20888266
[TBL] [Abstract][Full Text] [Related]
4. Population pharmacokinetic modeling of steady state clearance of carbamazepine and its epoxide metabolite from sparse routine clinical data.
Jiao Z; Shi XJ; Zhao ZG; Zhong MK
J Clin Pharm Ther; 2004 Jun; 29(3):247-56. PubMed ID: 15153086
[TBL] [Abstract][Full Text] [Related]
5. Population Pharmacokinetics of Topiramate in Japanese Pediatric and Adult Patients With Epilepsy Using Routinely Monitored Data.
Takeuchi M; Yano I; Ito S; Sugimoto M; Yamamoto S; Yonezawa A; Ikeda A; Matsubara K
Ther Drug Monit; 2017 Apr; 39(2):124-131. PubMed ID: 28230619
[TBL] [Abstract][Full Text] [Related]
6. Drug interaction profile of topiramate.
Bourgeois BF
Epilepsia; 1996; 37 Suppl 2():S14-S17. PubMed ID: 8641241
[TBL] [Abstract][Full Text] [Related]
7. Topiramate and phenytoin pharmacokinetics during repetitive monotherapy and combination therapy to epileptic patients.
Sachdeo RC; Sachdeo SK; Levy RH; Streeter AJ; Bishop FE; Kunze KL; Mather GG; Roskos LK; Shen DD; Thummel KE; Trager WF; Curtin CR; Doose DR; Gisclon LG; Bialer M
Epilepsia; 2002 Jul; 43(7):691-6. PubMed ID: 12102670
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic interactions of carbamazepine with some antiepileptic drugs during epilepsy treatment in children and adolescents.
Steinborn B
Rocz Akad Med Bialymst; 2005; 50 Suppl 1():9-15. PubMed ID: 16119616
[TBL] [Abstract][Full Text] [Related]
9. Effects of CYP3A4/5 and ABCB1 genetic polymorphisms on carbamazepine metabolism and transport in Chinese patients with epilepsy treated with carbamazepine in monotherapy and bitherapy.
Wang P; Yin T; Ma HY; Liu DQ; Sheng YH; Wang C; Zhou BT
Epilepsy Res; 2015 Nov; 117():52-7. PubMed ID: 26421491
[TBL] [Abstract][Full Text] [Related]
10. Nonlinear mixed effects modelling approach in investigating phenobarbital pharmacokinetic interactions in epileptic patients.
Vučićević K; Jovanović M; Golubović B; Kovačević SV; Miljković B; Martinović Ž; Prostran M
Eur J Clin Pharmacol; 2015 Feb; 71(2):183-90. PubMed ID: 25380628
[TBL] [Abstract][Full Text] [Related]
11. A comparative study of the effect of carbamazepine and valproic acid on the pharmacokinetics and metabolic profile of topiramate at steady state in patients with epilepsy.
Mimrod D; Specchio LM; Britzi M; Perucca E; Specchio N; La Neve A; Soback S; Levy RH; Gatti G; Doose DR; Maryanoff BE; Bialer M
Epilepsia; 2005 Jul; 46(7):1046-54. PubMed ID: 16026556
[TBL] [Abstract][Full Text] [Related]
12. Population pharmacokinetics modeling of oxcarbazepine to characterize drug interactions in Chinese children with epilepsy.
Wang Y; Zhang HN; Niu CH; Gao P; Chen YJ; Peng J; Liu MC; Xu H
Acta Pharmacol Sin; 2014 Oct; 35(10):1342-50. PubMed ID: 25220641
[TBL] [Abstract][Full Text] [Related]
13. Drug interaction and pharmacokinetic modeling of oxcarbazepine in korean patients with epilepsy.
Park KJ; Kim JR; Joo EY; Seo DW; Hong SB; Ko JW; Kim SR; Huh W; Lee SY
Clin Neuropharmacol; 2012; 35(1):40-4. PubMed ID: 22246398
[TBL] [Abstract][Full Text] [Related]
14. The effects of co-medications on lamotrigine clearance in Japanese children with epilepsy.
Takeuchi T; Natsume J; Kidokoro H; Ishihara N; Yamamoto H; Azuma Y; Ito Y; Kurahashi N; Tsuji T; Suzuki M; Itomi K; Yamada K; Kurahashi H; Abe S; Okumura A; Maruyama K; Negoro T; Watanabe K; Kojima S
Brain Dev; 2016 Sep; 38(8):723-30. PubMed ID: 27033151
[TBL] [Abstract][Full Text] [Related]
15. Population pharmacokinetics of lamotrigine with data from therapeutic drug monitoring in German and Spanish patients with epilepsy.
Rivas N; Buelga DS; Elger CE; Santos-Borbujo J; Otero MJ; Domínguez-Gil A; García MJ
Ther Drug Monit; 2008 Aug; 30(4):483-9. PubMed ID: 18641550
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic variability of four newer antiepileptic drugs, lamotrigine, levetiracetam, oxcarbazepine, and topiramate: a comparison of the impact of age and comedication.
Johannessen Landmark C; Baftiu A; Tysse I; Valsø B; Larsson PG; Rytter E; Johannessen SI
Ther Drug Monit; 2012 Aug; 34(4):440-5. PubMed ID: 22777154
[TBL] [Abstract][Full Text] [Related]
17. Effect of oral contraceptives on lamotrigine levels depends on comedication.
Wegner I; Wilhelm AJ; Lambrechts DA; Sander JW; Lindhout D
Acta Neurol Scand; 2014 Jun; 129(6):393-8. PubMed ID: 24571554
[TBL] [Abstract][Full Text] [Related]
18. Lack of pharmacokinetic interaction of levetiracetam on carbamazepine, valproic acid, topiramate, and lamotrigine in children with epilepsy.
Otoul C; De Smedt H; Stockis A
Epilepsia; 2007 Nov; 48(11):2111-5. PubMed ID: 17651416
[TBL] [Abstract][Full Text] [Related]
19. The impact of age on lamotrigine and oxcarbazepine kinetics: a historical cohort study.
Wegner I; Wilhelm AJ; Sander JW; Lindhout D
Epilepsy Behav; 2013 Oct; 29(1):217-21. PubMed ID: 23995050
[TBL] [Abstract][Full Text] [Related]
20. A nonlinear mixed effects modelling analysis of topiramate pharmacokinetics in patients with epilepsy.
Vovk T; Jakovljević MB; Kos MK; Janković SM; Mrhar A; Grabnar I
Biol Pharm Bull; 2010; 33(7):1176-82. PubMed ID: 20606310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]